Prilenia Plans To Continue With Pridopidine In ALS Despite Platform Study Miss

 
• By Joseph Haas
  
Neurodegeneration
Prilenia still hopes to advance pridopidine in ALS • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D